Gary Ingenito - 06 Dec 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
Chief Med. & Reg. Officer
Signature
/s/ Gary Ingenito
Issuer symbol
CPRX
Transactions as of
06 Dec 2023
Net transactions value
-$644,500
Form type
4
Filing time
08 Dec 2023, 17:00:09 UTC
Previous filing
17 Feb 2023
Next filing
12 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $56,500 +50,000 +130% $1.13* 88,367 06 Dec 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale $701,000 -50,000 -57% $14.02 38,367 06 Dec 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -50,000 -4.9% $0.000000 974,000 06 Dec 2023 Common Stock 50,000 $1.13 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Dr. Ingenito sold the shares on the open market for personal reasons and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a result of any disagreement with the Company.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.89 to $14.165 per share.
F3 Options vested in three annual tranches beginning on January 3, 2018.